In this issue:
JAK2 V617F as a relapse marker in myelofibrosis
TREATT: tranexamic acid in haematologic malignancies
EMBRACE: a model of care for bone marrow failure syndromes
CML13 ASCEND-CML: front-line asciminib for CP-CML
LUNA 2: rilzabrutinib for relapsed ITP
PERSEUS: daratumumab + VRd for transplant-eligible, newly diagnosed multiple myeloma
SYMPATICO: ibrutinib + venetoclax for relapsed/refractory mantle cell lymphoma
CAVEAT: venetoclax for NPM1- altered AML
RATHL: bleomycin & lung function in Hodgkin lymphoma
ALLG ALL06/09: ALL in adolescents & young adults
Please login below to download this issue (PDF)